• Vanda Pharmaceuticals Inc., of Washington, said the Israeli Ministry of Health granted market approval for Fanapt (iloperidone) for the treatment of schizophrenia. Vanda will commercialize the drug in Israel through its partner Megapharm Ltd., of Raanana, Israel.